Trial Watch: Peptide-based anticancer vaccines

Malignant cells express antigens that can be harnessed to elicit anticancer immune responses. One approach to achieve such goal consists in the administration of tumor-associated antigens (TAAs) or peptides thereof as recombinant proteins in the presence of adequate adjuvants. Throughout the past de...

Descripción completa

Detalles Bibliográficos
Autores principales: Pol, Jonathan, Bloy, Norma, Buqué, Aitziber, Eggermont, Alexander, Cremer, Isabelle, Sautès-Fridman, Catherine, Galon, Jérôme, Tartour, Eric, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485775/
https://www.ncbi.nlm.nih.gov/pubmed/26137405
http://dx.doi.org/10.4161/2162402X.2014.974411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485775/
https://www.ncbi.nlm.nih.gov/pubmed/26137405
http://dx.doi.org/10.4161/2162402X.2014.974411

Ejemplares similares